AFA
WST icon

Arlington Financial Advisors’s West Pharmaceutical WST Stock Holding History

Arlington Financial Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-544
Closed -$223K – 54
2022
Q1 		$223K Hold
544
– – 0.08% 50
2021
Q4 		$255K Sell
544
-10
-2% -$4.3K 0.09% 67
2021
Q3 		$235K Buy
+554
New +$234K 0.09% 54

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Arlington Financial Advisors's WST Position: Q2 2022 in Review

Arlington Financial Advisors sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 544 shares — an estimated $223K sold.

Arlington Financial Advisors first reported a position in WST in Q3 2021 and held it in 3 quarters. The position peaked at $255K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Arlington Financial Advisors reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Arlington Financial Advisors sold 544 West Pharmaceutical shares in Q2 2022, an estimated $223K.
  • Arlington Financial Advisors first reported a position in West Pharmaceutical in Q3 2021 and held it in 3 quarters.
  • Arlington Financial Advisors's West Pharmaceutical position peaked at $255K in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Arlington Financial Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.